Journal
EUROPEAN JOURNAL OF HUMAN GENETICS
Volume 17, Issue 5, Pages 687-692Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ejhg.2008.228
Keywords
autism; CNV; genetic modifier; learning disability; schizophrenia; phenotypic variability
Funding
- Autism Genome Project (AGP)
- Autism Speaks (USA)
- Genome Canada (Canada)
- Health Research Board (HRB
- Ireland)
- Hilibrand Foundation (USA)
- Medical Research Council (UK)
- National Institute of Health (NIH, USA)
- Nancy Laurie Marks Family Foundation
- Simons Foundation
- Wellcome Trust
- Deutsche Forschungsgemeinschaft
- Oxford Partnership Comprehensive Biomedical Research Centre
- Department of Health's NIHR Biomedical Research Centres
- MRC [G0601030] Funding Source: UKRI
- Medical Research Council [G0601030] Funding Source: researchfish
Ask authors/readers for more resources
Autism and mental retardation (MR) show high rates of comorbidity and potentially share genetic risk factors. In this study, a rare similar to 2Mb microdeletion involving chromosome band 15q13.3 was detected in a multiplex autism family. This genomic loss lies between distal break points of the Prader-Willi/Angelman syndrome locus and was first described in association with MR and epilepsy. Together with recent studies that have also implicated this genomic imbalance in schizophrenia, our data indicate that this CNV shows considerable phenotypic variability. Further studies should aim to characterise the precise phenotypic range of this CNV and may lead to the discovery of genetic or environmental modifiers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available